CHEK2 1100delC and colorectal cancer -: art. no. e110

[1] Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (21) : 1481 - 1487

[2] Chk2 kinase - A busy messenger [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2001, 2 (12) : 877 - 886

[3] Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome [J]. SCIENCE, 1999, 286 (5449) : 2528 - 2531

[4] Detection of 11 germline inactivating TP53 mutations and absence of TP63 and HCHK2 mutations in 17 French families with Li-Fraumeni or Li-Fraumeni-like syndrome [J]. JOURNAL OF MEDICAL GENETICS, 2001, 38 (04) : 253 - 256

[5] Mutations in CHEK2 associated with prostate cancer risk [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (02) : 270 - 280

[6] CONFORMATION-SENSITIVE GEL-ELECTROPHORESIS FOR RAPID DETECTION OF SINGLE-BASE DIFFERENCES IN DOUBLE-STRANDED PCR PRODUCTS AND DNA FRAGMENTS - EVIDENCE FOR SOLVENT-INDUCED BENDS IN DNA HETERODUPLEXES [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (21) : 10325 - 10329

[7] Mutation analysis of the CHK2 gene in breast carcinoma and other cancers [J]. BREAST CANCER RESEARCH, 2002, 4 (03)

[8] A RAPID NONENZYMATIC METHOD FOR THE PREPARATION OF HMW DNA FROM BLOOD FOR RFLP STUDIES [J]. NUCLEIC ACIDS RESEARCH, 1991, 19 (19) : 5444 - 5444

[9] Lee SB, 2001, CANCER RES, V61, P8062

[10] Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations [J]. NATURE GENETICS, 2002, 31 (01) : 55 - 59

[1] Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (21) : 1481 - 1487

[2] Chk2 kinase - A busy messenger [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2001, 2 (12) : 877 - 886

[3] Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome [J]. SCIENCE, 1999, 286 (5449) : 2528 - 2531

[4] Detection of 11 germline inactivating TP53 mutations and absence of TP63 and HCHK2 mutations in 17 French families with Li-Fraumeni or Li-Fraumeni-like syndrome [J]. JOURNAL OF MEDICAL GENETICS, 2001, 38 (04) : 253 - 256

[5] Mutations in CHEK2 associated with prostate cancer risk [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (02) : 270 - 280

[6] CONFORMATION-SENSITIVE GEL-ELECTROPHORESIS FOR RAPID DETECTION OF SINGLE-BASE DIFFERENCES IN DOUBLE-STRANDED PCR PRODUCTS AND DNA FRAGMENTS - EVIDENCE FOR SOLVENT-INDUCED BENDS IN DNA HETERODUPLEXES [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (21) : 10325 - 10329

[7] Mutation analysis of the CHK2 gene in breast carcinoma and other cancers [J]. BREAST CANCER RESEARCH, 2002, 4 (03)

[8] A RAPID NONENZYMATIC METHOD FOR THE PREPARATION OF HMW DNA FROM BLOOD FOR RFLP STUDIES [J]. NUCLEIC ACIDS RESEARCH, 1991, 19 (19) : 5444 - 5444

[9] Lee SB, 2001, CANCER RES, V61, P8062

[10] Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations [J]. NATURE GENETICS, 2002, 31 (01) : 55 - 59